Patent · US Active

Valerian composition and related methods

US11701425B2 · kind B2 · utility

0Cited by
14References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2021
Grant dateJul 18, 2023
Priority date
Expiry dateOct 6, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A valerian composition includes valerian and an acidifying agent blended together in a pharmaceutically acceptable hydrogel-forming polymer matrix. An expedited release portion of the dosage form includes 5% to 50% of the valerian and is effective to release the valerian therein within 2 hours from placement in a 0.1 N HCl solution. A sustained release portion of the dosage form includes the remainder of the valerian and is effective to release the valerian therein within 10 hours from placement in a phosphate buffer with a pH of 6.8.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.